Home › Funds › Prosight Management, LP › RCKT

Prosight Management, LP position in RCKT

ROCKET PHARMACEUTICALS INC · Health Care

Prosight Management, LP reported holding 595,024 shares of RCKT (ROCKET PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$1.6M, representing 0.30% of its reported portfolio and ranking #27 among its reported holdings. Prosight Management, LP has disclosed RCKT holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)595.02K sh
Reported value held$1.56M
Portfolio Weight0.30%
First reportedQ3 2024
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Prosight Management, LP's RCKT position evolved

Prosight Management, LP first disclosed a stake in RCKT in Q3 2024 at 159,369 shares (US$2.9M). The position peaked in Q4 2024 at 1,088,706 shares, worth US$13.7M. Across 9 filings, Prosight Management, LP increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 595,024 shares valued at US$1.6M — a reduction of -104,976 shares quarter over quarter.. Notable position changes include a 583% increase in Q4 2024 (shares fell 47% over the following quarter), a 36% increase in Q1 2025 (shares fell 63% over the following quarter), a 41% trim in Q4 2025 (shares rose 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 159.37K $2.94M New
Q4 2024 1.09M $13.69M Add
Q1 2025 1.48M $9.87M Add
Q2 2025 1.58M $3.87M Add
Q3 2025 1.27M $4.13M Reduce
Q4 2025 743.94K $2.61M Reduce
Q1 2026 683.86K $2.45M Reduce
Q2 2026 700.00K $2.39M Add
Q3 2026 595.02K $1.56M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RCKT and 13F data

RCKT (ROCKET PHARMACEUTICALS INC) is a Health Care company. 15 other funds we track also report a position in RCKT — the largest reported positions include RTW INVESTMENTS, LP (US$60.5M), Newtyn Management, LLC (US$13.7M), Maverick Capital (US$13.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RCKT

All RCKT fund holders →

FAQ

How long has Prosight Management, LP held RCKT?

Prosight Management, LP has disclosed RCKT holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is Prosight Management, LP's current position in RCKT?

As of Q3 2026, Prosight Management, LP holds 595.02K shares of RCKT (ROCKET PHARMACEUTICALS INC), valued at $1.56M, representing 0.30% of its reported portfolio and ranking #27.

Has Prosight Management, LP been buying or selling RCKT?

In the latest 13F filing (Q3 2026), Prosight Management, LP reduced its position in RCKT. The position peaked in Q4 2024 at 1.09M shares.

Which other funds hold RCKT?

Other major institutional holders of RCKT include RTW INVESTMENTS, LP, Newtyn Management, LLC, Maverick Capital, among 15 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.